17.06
0.17 (1.01%)
| Previous Close | 16.89 |
| Open | 16.85 |
| Volume | 897,204 |
| Avg. Volume (3M) | 1,688,593 |
| Market Cap | 2,206,570,752 |
| Price / Earnings (Forward) | 19.76 |
| Price / Sales | 0.650 |
| Price / Book | 1.25 |
| 52 Weeks Range | |
| Earnings Date | 10 Nov 2025 |
| Profit Margin | -6.09% |
| Operating Margin (TTM) | 11.55% |
| Diluted EPS (TTM) | -1.53 |
| Quarterly Revenue Growth (YOY) | 8.20% |
| Total Debt/Equity (MRQ) | 108.05% |
| Current Ratio (MRQ) | 1.89 |
| Operating Cash Flow (TTM) | 265.40 M |
| Levered Free Cash Flow (TTM) | 142.56 M |
| Return on Assets (TTM) | 3.97% |
| Return on Equity (TTM) | -0.35% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Surgery Partners, Inc. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -4.0 |
| Average | 1.25 |
|
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 1.51% |
| % Held by Institutions | 111.91% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 36.00 (Cantor Fitzgerald, 111.02%) | Buy |
| Median | 29.00 (69.99%) | |
| Low | 18.00 (Barclays, 5.51%) | Hold |
| Average | 26.57 (55.74%) | |
| Total | 5 Buy, 2 Hold | |
| Avg. Price @ Call | 16.34 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 24 Nov 2025 | 20.00 (17.23%) | Hold | 16.29 |
| 18 Sep 2025 | 27.00 (58.26%) | Hold | 22.03 | |
| Barclays | 21 Nov 2025 | 18.00 (5.51%) | Hold | 15.84 |
| Mizuho | 17 Nov 2025 | 22.00 (28.96%) | Buy | 15.06 |
| UBS | 13 Nov 2025 | 29.00 (69.99%) | Buy | 15.31 |
| Benchmark | 11 Nov 2025 | 30.00 (75.85%) | Buy | 15.75 |
| RBC Capital | 11 Nov 2025 | 31.00 (81.71%) | Buy | 15.75 |
| Cantor Fitzgerald | 07 Oct 2025 | 36.00 (111.02%) | Buy | 20.39 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 10 Nov 2025 | Announcement | Surgery Partners, Inc. Announces Third Quarter 2025 Results |
| 24 Oct 2025 | Announcement | Surgery Partners, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call Details |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |